发明名称 A stable pharmaceutical formulation comprising torsemide modification II
摘要 <p>Novel, stable pharmaceutical formulations for the oral administration of high purity torsemide modification II are disclosed. These formulations release high purity torsemide modification II in water at a constant and high purity rate, and the high purity torsemide modification II therein does not rearrange to torsemide modification I over time. Methods for their manufacture are also disclosed.</p>
申请公布号 SK11632003(A3) 申请公布日期 2004.04.06
申请号 SK20030001163 申请日期 2001.02.21
申请人 TEVA PHARMACEUTICAL INDUSTRIES LTD. 发明人 LEIBOVICI MINUTZA;TENENGAUZER RUTH;KOPEL MIRA;ARONHIME JUDITH;KORDOVA MARCO
分类号 A61K9/20;A61K;A61K31/44;A61K47/12;A61K47/26;A61K47/32;A61K47/38;A61P7/10;A61P9/00;A61P9/12;(IPC1-7):A61K31/44 主分类号 A61K9/20
代理机构 代理人
主权项
地址